Studies of the interaction of hematopoietic cells and viruses have mainly concentrated on members of the Parvoviridae and with our interest in hepatitis-associated aplastic anemia, novel putative hepatitis agents. B19 parvovirus infects erythroid progenitor cells and infection in humans causes both the hematologic syndromes transient aplastic crisis and pure red cell aplasia as well as the common childhood exanthem fifth disease. Provoked by reports that B19 parvovirus might be involved in the etiology of hepatitis, we have analyzed using the polymerase chain reaction a large number of liver samples: in our experience, approximately 30% of liver tissue contain detectable B19 parvovirus, regardless of the primary diagnosis. These results suggest that the virus may persist in small amounts in visceral tissue without medical consequence. We have also discovered and characterized two new members of the Erythrovirus genus that infect pig-tailed macaque and rhesus macaque monkeys. This and other Erythroviruses share genetic homology and functional characteristics with B19 parvovirus. One member of the genus, simian parvovirus, may offer an animal model for human disease, as hydrops fatalis has been reproduced by experimental uterine inoculation during the mid-trimester of pregnancy. In vaccine trials, rhesus monkeys have been immunized with empty B19 parvovirus capsids that were formulated with several experimental adjuvants in order to elicit high titers of neutralizing antibodies. One such formulation should prove appropriate for a human vaccine to prevent parvovirus disease. Other parvoviral studies include development of adeno-associated virus vectors based on a second human adeno-associated virus AAV-3, and comparative studies of the tissue tropism of with the conventional AAV-2; further experiments to determine early the early events of AAV infection, including the nature of the cell surface receptor for AAV-2, and the interactions of the structural and non-structural proteins with cellular proteins; and functional analysis of the non-structural protein of B19 parvovirus, which is responsible for viral cell killing. Our studies of putuative novel hepatitis viruses include the flavivirus, hepatitis G or GBV-C, an enterovirus A2, and a putative parvovirus or circovirus TTV. Hepatitis G/GBV-C RNA has been detected by gene amplification in a large number of normal individuals including children: serum samples from non-transfused children in the Washington area show that 9% of plasma samples contain GBV-C sequences, and with our recently developed antibody test, an additional13% have GBV-C specific antibody indicating previous infection. Testing of samples from hepatitis patients suggest that this virus is not associated with hepatitis, but its tissue tropism, the nature of replication in the absence of a core protein, and the relationship of viral infection to disease remain important current areas of research. Currently TTV sequences are detected in 20% of American blood donors, and an increased number of children (~30%), but the high degree of sequence variation suggests that the current assay underestimates the true prevalence. The nature of the virus, and its tissue tropism and also active areas of research.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Intramural Research (Z01)
Project #
1Z01HL002319-15
Application #
6109224
Study Section
Special Emphasis Panel (HB)
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wong, Susan; Brown, Kevin E (2006) Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35:407-13
Lu, Jun; Zhi, Ning; Wong, Susan et al. (2006) Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 193:582-90
Prikhod'ko, Grigori G; Vasilyeva, Irina; Reyes, Herbert et al. (2005) Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies. Transfusion 45:1011-9
Mamyrova, Gulnara; Rider, Lisa G; Haagenson, Laura et al. (2005) Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 294:2170-1
Gergely Jr, Peter; Pullmann, Rudolf; Stancato, Christina et al. (2005) Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol 116:124-34
Vashisht, Kapil; Faaberg, Kay S; Aber, Amanda L et al. (2004) Splice junction map of simian parvovirus transcripts. J Virol 78:10911-9
Liu, Zhengwen; Qiu, Jianming; Cheng, Fang et al. (2004) Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol 78:12929-39
Zhi, Ning; Zadori, Zoltan; Brown, Kevin E et al. (2004) Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318:142-52
Young, Neal S; Brown, Kevin E (2004) Parvovirus B19. N Engl J Med 350:586-97
Lu, Jun; Basu, Atanu; Melenhorst, J Joseph et al. (2004) Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103:4588-93

Showing the most recent 10 out of 41 publications